Somerset, N.J. (PRWEB) April 08, 2015
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Mr. Stephen Tindal, Director, Scientific Affairs, will host a workshop at the upcoming American Drug Delivery and Formulation Summit, to be held at the Hilton Orange County/Costa Mesa, California, on April 14th – 15th, 2015.
Mr. Tindal’s workshop session, on Wednesday, April 15th, at 11.35 a.m., is entitled “Applying Softgel Capsules to Enhance Solubility and Get to Market Faster” and will discuss the suitability of softgel formulations within the drug development path, also how solubility issues can be overcome using the technology. Developments in lipid-based drug delivery systems have enabled improved bioavailability in macromolecular oral therapies and Mr. Tindal will present a case study on this subject.
Mr. Tindal is based at Catalent’s Somerset R&D facility and has nearly 30 years of experience in softgel formulation. He has wide expertize in commercializing many Rx, Gx, OTC and VMS products. His current role sees him supporting customers in applying softgel technologies to overcome specific API challenges. Mr. Tindal holds a B.Sc. in Chemistry and Analytical Science from Loughborough University, UK, and is a member of the Catalent Applied Drug Delivery Institute.
For more information on the Drug Delivery and Formulation Summit, visit: http://www.ddfsummit.com and to arrange a meeting with Mr. Tindal, contact Richard Kerns at NEPR- richard(at)nepr(dot)eu